Advanced glycation end products induce inflammaging in periodontal ligament fibroblasts through RAGE/AKT/mTOR/glycolysis pathway
DOI:
https://doi.org/10.2340/aos.v84.44581Keywords:
periodontitis, advanced glycation end products, glycolysis, inflammaging, Akt/mTOR pathwayAbstract
Background: Inflammaging plays a pivotal role in the pathogenesis of multiple age-related diseases, including periodontitis. Advanced glycation end products (AGEs) are known to induce inflammaging and exacerbate periodontitis. However, the mechanisms by which AGEs promote inflammaging remain unclear. This study aimed to investigate the mechanisms underlying AGE-induced inflammaging.
Methods and results: Human periodontal ligament fibroblasts (hPDLFs) were extracted and stimulated with lipopolysaccharide (LPS), with prior treatment using AGEs. The expression of pro-inflammatory cytokines was measured to explore the role of AGEs in LPS-induced inflammation. Subsequently, hPDLFs were treated with AGEs and pre-incubated with 2-deoxyglucose (2-DG, a glycolysis inhibitor), Ly294002 (an AKT/mTOR pathway inhibitor), and FPS-ZM1 (a receptor for advanced glycation end product [RAGE] antagonist) to assess the levels of inflammaging markers, glycolysis, AKT/mTOR pathway activation, and RAGE expression, along with the potential relationships among these factors. Our findings demonstrated that AGEs significantly increased the expression of pro-inflammatory cytokines in response to LPS stimulation. Additionally, AGEs alone elevated the levels of inflammaging factors, including cell senescence, senescence-associated secretory phenotype factors, SA-β-Gal expression, glycolysis markers, and AKT/mTOR pathway activation. Furthermore, inhibiting glycolysis reduced AGE-induced inflammaging, while blocking the AKT/mTOR pathway, suppressed both AGE-induced inflammaging and glycolysis. Antagonizing RAGE effectively blocked AGE-induced inflammaging, glycolysis, and AKT/mTOR pathway activation.
Conclusions: Our study indicated that AGE-induced inflammaging through binding to RAGE to activate the AKT/mTOR pathway and eventually enhancing glycolysis level, which may contribute to the increased inflammatory response triggered by LPS. These findings suggest that inflammaging is a critical mechanism through which AGEs exacerbate periodontitis.
Downloads
References
Slots J. Periodontitis: facts, fallacies and the future. Periodontol 2000. 2017;75:7–23. https://doi.org/10.1111/prd.12221 DOI: https://doi.org/10.1111/prd.12221
Kassebaum NJ, Bernabé E, Dahiya M, Bhandari B, Murray CJ, Marcenes W. Global burden of severe periodontitis in 1990–2010: a system-atic review and meta-regression. J Dent Res. 2014;93:1045–53. https://doi.org/10.1177/0022034514552491 DOI: https://doi.org/10.1177/0022034514552491
Genco RJ, Sanz M. Clinical and public health implications of periodontal and systemic diseases: an overview. Periodontol 2000. 2020;83:7–13. https://doi.org/10.1111/prd.12344 DOI: https://doi.org/10.1111/prd.12344
Preshaw PM, Alba AL, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K, et al. Periodontitis and diabetes: a two-way relationship. Dia-betologia. 2012;55:21–31. https://doi.org/10.1007/s00125-011-2342-y DOI: https://doi.org/10.1007/s00125-011-2342-y
Marruganti C, Suvan JE, D’Aiuto F. Periodontitis and metabolic diseases (diabetes and obesity): tackling multimorbidity. Periodontol 2000. 2023. https://doi.org/10.1111/prd.12536 DOI: https://doi.org/10.1111/prd.12536
Chopra A, Jayasinghe TN, Eberhard J. Are inflamed periodontal tissues endogenous source of advanced glycation end-products (AGEs) in individuals with and without diabetes mellitus? A systematic review. Biomolecules. 2022;12:642. https://doi.org/10.3390/biom12050642 DOI: https://doi.org/10.3390/biom12050642
Twarda-Clapa A, Olczak A, Białkowska AM, Koziołkiewicz M. Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs. Cells. 2022;11:1312. https://doi.org/10.3390/cells11081312 DOI: https://doi.org/10.3390/cells11081312
Sonnenschein SK, Meyle J. Local inflammatory reactions in patients with diabetes and periodontitis. Periodontol 2000. 2015;69:221–54. https://doi.org/10.1111/prd.12089 DOI: https://doi.org/10.1111/prd.12089
Baima G, Romandini M, Citterio F, Romano F, Aimetti M. Periodontitis and accelerated biological aging: a geroscience approach. J Dent Res. 2022;101:125–32. https://doi.org/10.1177/00220345211037977 DOI: https://doi.org/10.1177/00220345211037977
Clark D, Radaic A, Kapila Y. Cellular mechanisms of inflammaging and periodontal disease. Front Dent Med. 2022;3:844865. https://doi.org/10.3389/fdmed.2022.844865 DOI: https://doi.org/10.3389/fdmed.2022.844865
Prattichizzo F, De Nigris V, La Sala L, Procopio AD, Olivieri F, Ceriello A. ‘Inflammaging’ as a druggable target: a senescence-associated secretory phenotype-centered view of type 2 diabetes. Oxid Med Cell Longev. 2016;2016:1810327. https://doi.org/10.1155/2016/1810327 DOI: https://doi.org/10.1155/2016/1810327
O’Sullivan O, Ladlow P, Steiner K, Hillman C, Stocks J, Bennett AN, et al. Current status of catabolic, anabolic and inflammatory bi-omarkers associated with structural and symptomatic changes in the chronic phase of post-traumatic knee osteoarthritis – a systematic review. Osteoarthr Cartil Open. 2023;5:100412. https://doi.org/10.1016/j.ocarto.2023.100412 DOI: https://doi.org/10.1016/j.ocarto.2023.100412
Nandakumar KS, Fang Q, Wingbro Ågren I, Bejmo ZF. Aberrant activation of immune and non-immune cells contributes to joint inflamma-tion and bone degradation in rheumatoid arthritis. Int J Mol Sci. 2023;24:15883. https://doi.org/10.3390/ijms242115883 DOI: https://doi.org/10.3390/ijms242115883
Zhang P, Lu B, Zhu R, Yang D, Liu W, Wang Q, et al. Hyperglycemia accelerates inflammaging in the gingival epithelium through inflam-masomes activation. J Periodontal Res. 2021;56:667–78. https://doi.org/10.1111/jre.12863 DOI: https://doi.org/10.1111/jre.12863
Albuquerque-Souza E, Crump KE, Rattanaprukskul K, Li Y, Shelling B, Xia-Juan X, et al. TLR9 mediates periodontal aging by fostering senes-cence and inflammaging. J Dent Res. 2022;101:1628–36. https://doi.org/10.1177/00220345221110108 DOI: https://doi.org/10.1177/00220345221110108
Shen CY, Li KJ, Wu CH, Lu CH, Kuo YM, Hsieh SC, et al. Unveiling the molecular basis of inflamm-aging induced by advanced glycation end products (AGEs)-modified human serum albumin (AGE-HSA) in patients with different immune-mediated diseases. Clin Immunol. 2023;252:109655. https://doi.org/10.1016/j.clim.2023.109655 DOI: https://doi.org/10.1016/j.clim.2023.109655
Giuliani A, Giudetti AM, Vergara D, Del Coco L, Ramini D, Caccese S, et al. Senescent endothelial cells sustain their senescence-associated secretory phenotype (SASP) through enhanced fatty acid oxidation. Antioxidants (Basel). 2023;12:1956. https://doi.org/10.3390/antiox12111956 DOI: https://doi.org/10.3390/antiox12111956
Song MJ, Park CH, Kim H, Han S, Lee SH, Lee DH, et al. Carnitine acetyltransferase deficiency mediates mitochondrial dysfunction- induced cellular senescence in dermal fibroblasts. Aging Cell. 2023;22:e14000. https://doi.org/10.1111/acel.14000 DOI: https://doi.org/10.1111/acel.14000
Tewari D, Patni P, Bishayee A, Sah AN, Bishayee A. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy. Semin Cancer Biol. 2022;80:1–17. https://doi.org/10.1016/j.semcancer.2019.12.008 DOI: https://doi.org/10.1016/j.semcancer.2019.12.008
Atawia RT, Batori RK, Jordan CR, Kennard S, Antonova G, Bruder-Nascimento T, et al. Type 1 diabetes impairs endothelium-dependent relaxation via increasing endothelial cell glycolysis through advanced glycation end products, PFKFB3, and Nox1-mediated mechanisms. Hypertension. 2023;80:2059–71. https://doi.org/10.1161/hypertensionaha.123.21341 DOI: https://doi.org/10.1161/HYPERTENSIONAHA.123.21341
Shirai T, Nazarewicz RR, Wallis BB, Yanes RE, Watanabe R, Hilhorst M, et al. The glycolytic enzyme PKM2 bridges metabolic and inflamma-tory dysfunction in coronary artery disease. J Exp Med. 2016;213:337–54. https://doi.org/10.1084/jem.20150900 DOI: https://doi.org/10.1084/jem.20150900
Liao EC, Hsu YT, Chuah QY, Lee YJ, Hu JY, Huang TC, et al. Radiation induces senescence and a bystander effect through metabolic altera-tions. Cell Death Dis. 2014;5:e1255. https://doi.org/10.1038/cddis.2014.220 DOI: https://doi.org/10.1038/cddis.2014.220
Kruglov V, Jang IH, Camell CD. Inflammaging and fatty acid oxidation in monocytes and macrophages. Immunometabolism (Cobham). 2024;6:e00038. https://doi.org/10.1097/in9.0000000000000038 DOI: https://doi.org/10.1097/IN9.0000000000000038
Ikegami K, Yamashita M, Suzuki M, Nakamura T, Hashimoto K, Kitagaki J, et al. Cellular senescence with SASP in periodontal ligament cells triggers inflammation in aging periodontal tissue. Aging (Albany NY). 2023;15:1279–305. https://doi.org/10.18632/aging.204569 DOI: https://doi.org/10.18632/aging.204569
Naruishi K. Biological roles of fibroblasts in periodontal diseases. Cells. 2022;11:3345. https://doi.org/10.3390/cells11213345 DOI: https://doi.org/10.3390/cells11213345
Suh HN, Ji JY, Heo JS. Translating proteome and transcriptome dynamics of periodontal ligament stem cell-derived secretome/conditioned medium in an in vitro model of periodontitis. BMC Oral Health. 2024;24:390. https://doi.org/10.1186/s12903-024-04167-z DOI: https://doi.org/10.1186/s12903-024-04167-z
Kobayashi H, Yoshimoto C, Matsubara S, Shigetomi H, Imanaka S. Altered energy metabolism, mitochondrial dysfunction, and redox im-balance influencing reproductive performance in granulosa cells and oocyte during aging. Reprod Sci. 2024;31:906–16. https://doi.org/10.1007/s43032-023-01394-7 DOI: https://doi.org/10.1007/s43032-023-01394-7
Marrocco A, Ortiz LA. Role of metabolic reprogramming in pro- inflammatory cytokine secretion from LPS or silica-activated macrophages. Front Immunol. 2022;13:936167. https://doi.org/10.3389/fimmu.2022.936167 DOI: https://doi.org/10.3389/fimmu.2022.936167
Sun Q, Chen X, Ma J, Peng H, Wang F, Zha X, et al. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc Natl Acad Sci U S A. 2011;108:4129–34. https://doi.org/10.1073/pnas.1014769108 DOI: https://doi.org/10.1073/pnas.1014769108
Murao N, Yokoi N, Takahashi H, Hayami T, Minami Y, Seino S. Increased glycolysis affects β-cell function and identity in aging and diabe-tes. Mol Metab. 2022;55:101414. https://doi.org/10.1016/j.molmet.2021.101414 DOI: https://doi.org/10.1016/j.molmet.2021.101414
James EL, Michalek RD, Pitiyage GN, de Castro AM, Vignola KS, Jones J, et al. Senescent human fibroblasts show increased glycolysis and redox homeostasis with extracellular metabolomes that overlap with those of irreparable DNA damage, aging, and disease. J Proteome Res. 2015;14:1854–71. https://doi.org/10.1021/pr501221g DOI: https://doi.org/10.1021/pr501221g
Xu S, Deng KQ, Lu C, Fu X, Zhu Q, Wan S, et al. Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects. Metabolism. 2024;155:155832. https://doi.org/10.1016/j.metabol.2024.155832 DOI: https://doi.org/10.1016/j.metabol.2024.155832
Manosalva C, Alarcon P, Quiroga J, Teuber S, Carretta MD, Bustamante H, et al. Bovine tumor necrosis factor-alpha increases IL-6, IL-8, and PGE2 in bovine fibroblast-like synoviocytes by metabolic reprogramming. Sci Rep. 2023;13:3257. https://doi.org/10.1038/s41598-023-29851-y DOI: https://doi.org/10.1038/s41598-023-29851-y
Chen S, Tao Y, Wang Q, Ren J, Jing Y, Huang J, et al. Glucose induced-AKT/mTOR activation accelerates glycolysis and promotes cell surviv-al in acute myeloid leukemia. Leuk Res. 2023;128:107059. https://doi.org/10.1016/j.leukres.2023.107059 DOI: https://doi.org/10.1016/j.leukres.2023.107059
Chen L, Li X, Deng Y, Chen J, Huang M, Zhu F, et al. The PI3K-Akt-mTOR pathway mediates renal pericyte-myofibroblast transition by en-hancing glycolysis through HKII. J Transl Med. 2023;21:323. https://doi.org/10.1186/s12967-023-04167-7 DOI: https://doi.org/10.1186/s12967-023-04167-7
Wang K, Li J, Zhou B. KIAA0101 knockdown inhibits glioma progression and glycolysis by inactivating the PI3K/AKT/mTOR pathway. Metab Brain Dis. 2022;37:489–99. https://doi.org/10.1007/s11011-021-00863-9 DOI: https://doi.org/10.1007/s11011-021-00863-9
Duggan MR, Weaver M, Khalili K. PAM (PIK3/AKT/mTOR) signaling in glia: potential contributions to brain tumors in aging. Aging (Albany NY). 2021;13:1510–27. https://doi.org/10.18632/aging.202459 DOI: https://doi.org/10.18632/aging.202459
Published
Issue
Section
License
Copyright (c) 2025 Lin Xiong, Jiayu Shu, Hongli Gao, Yufeng Qin, Yuehan Zhang, Xuelian Chang, Qiang Dong, Helin Chen
This work is licensed under a Creative Commons Attribution 4.0 International License.
Acta Odontologica Scandinavica publishes high quality original research papers as well as critical reviews relevant on diseases of the oral cavity, their treatment, epidemiology and associated biomaterials and their development.
